Publicacións (18) Publicacións de ÁNGEL CORES ESPERÓN

2023

  1. Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models

    European Journal of Medicinal Chemistry, Vol. 245

  2. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease

    Bioorganic and Medicinal Chemistry, Vol. 91

  3. Quinones as Neuroprotective Agents

    Antioxidants, Vol. 12, Núm. 7

2022

  1. Curcumin-piperlongumine hybrids with a multitarget profile elicit neuroprotection in in vitro models of oxidative stress and hyperphosphorylation

    Antioxidants, Vol. 11, Núm. 1

  2. Enantioselective Synthesis and Pharmacological Evaluation of Aza‐CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease

    Antioxidants, Vol. 11, Núm. 1

  3. Fluorescence Sensors Based on Hydroxycarbazole for the Determination of Neurodegeneration-Related Halide Anions

    Biosensors, Vol. 12, Núm. 3

  4. Multicomponent Reactions for the Synthesis of Active Pharmaceutical Ingredients

    Pharmaceuticals, Vol. 15, Núm. 8

  5. Organocatalysis in Synthetic Heterocyclic Chemistry

    Heterocycles: Synthesis, Catalysis, Sustainability, and Characterization (wiley), pp. 85-115

  6. PROTAC: Redirigiendo los sistemas de degradación de proteínas a nuevos sustratos

    Anales de la Real Academia Nacional de Farmacia, Vol. 88, Núm. 1, pp. 45-60

2021

  1. (E)-3-((2-Fluorophenyl)(hydroxy)methylene)imidazo[1, 2-a]pyridin-2(3H)-one

    MolBank, Vol. 2021, Núm. 2

  2. Bisavenathramide analogues as nrf2 inductors and neuroprotectors in in vitro models of oxidative stress and hyperphosphorylation

    Antioxidants, Vol. 10, Núm. 6

  3. Emerging targets in drug discovery against neurodegenerative diseases: Control of synapsis disfunction by the RhoA/ROCK pathway

    European Journal of Medicinal Chemistry, Vol. 225

  4. Enhanced stability and bioactivity of natural anticancer topoisomerase i inhibitors through cyclodextrin complexation

    Pharmaceutics, Vol. 13, Núm. 10

2020

  1. Aza-CGP37157-lipoic hybrids designed as novel Nrf2-inducers and antioxidants exert neuroprotection against oxidative stress and show neuroinflammation inhibitory properties

    Drug Development Research, Vol. 81, Núm. 3, pp. 283-294

  2. NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases

    Biomolecules, Vol. 10, Núm. 6

  3. Synthesis of 1,4-Diazepanes and Benzo[ b][1,4]diazepines by a Domino Process Involving the in Situ Generation of an Aza-Nazarov Reagent

    Journal of Organic Chemistry, Vol. 85, Núm. 18, pp. 11924-11933

2017

  1. Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease

    Scientific Reports, Vol. 7

2016

  1. Three-component access to 2-pyrrolin-5-ones and their use in target-oriented and diversity-oriented synthesis

    RSC Advances, Vol. 6, Núm. 45, pp. 39433-39443